TheraRadar

Metabolic Drugs

348 FDA-approved drugs

TheraRadar tracks 348 FDA-approved metabolic drugs from 137 companies across 30 drug classes, led by Novo Nordisk, with 1,438 active clinical trials in the pipeline. Explore recent approvals, top companies, active trials by indication, and drug classes for Metabolic.

Metabolic Approvals by Year

11
'15
10
'16
14
'17
2
'18
15
'19
6
'20
9
'21
8
'22
10
'23
7
'24
9
'25
8
'26

Recent Metabolic Drug Approvals

LANGLARA
INSULIN GLARGINE-ALDY
LANGLARA is indicated to improve glycemic control in adult and pediatric patients with diabetes mell...
2026-04-29
SUNSHINE LAKE PHARMA CO LTD
CANAGLIFLOZIN
CANAGLIFLOZIN
2026-04-14
Novartis
DAPAGLIFLOZIN
DAPAGLIFLOZIN
Dapagliflozin tablets are indicated: To reduce the risk of hospitalization for heart failure in adul...
2026-04-06
INVENTIA
SGLT2
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
DAPAGLIFLOZIN
Dapagliflozin and metformin HCl extended-release tablets are a combination of dapagliflozin and metf...
2026-04-06
Sun Pharma
SGLT2
DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE
DAPAGLIFLOZIN
Dapagliflozin and saxagliptin tablets are indicated as an adjunct to diet and exercise to improve gl...
2026-04-06
MSN
GLP-1GIPSGLT2
FOUNDAYO
ORFORGLIPRON CALCIUM
FOUNDAYO TM is indicated in combination with a reduced-calorie diet and increased physical activity ...
2026-04-01
Eli Lilly
GLP-1
AWIQLI FLEXTOUCH
INSULIN ICODEC
Awiqli is indicated as an adjunct to diet and exercise to improve glycemic control in adults with ty...
2026-03-26
Novo Nordisk
DESMODA
DESMOPRESSIN ACETATE
nephrogenic diabetes insipidus...
2026-02-25
ETON
SITAGLIPTIN PHOSPHATE
SITAGLIPTIN PHOSPHATE
Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in ...
2025-12-29
Novartis
GLP-1GIPDPP-4
LEROCHOL
LERODALCIBEP-LIGA
LEROCHOL TM is indicated as an adjunct to diet and exercise to reduce low-density lipoprotein choles...
2025-12-12
LIB THERAPEUTICS, INC.
PCSK9
REDEMPLO
PLOZASIRAN SODIUM
REDEMPLO is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomic...
2025-11-18
ARROWHEAD
EYDENZELT
AFLIBERCEPT-BOAV
2025-10-02
CELLTRION INC
PlGFVEGF-A
KIRSTY
INSULIN ASPART-XJHZ
KIRSTY is indicated to improve glycemic control in adults and pediatric patients with diabetes melli...
2025-07-15
BIOCON BIOLOGICS INC
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
METFORMIN HYDROCHLORIDE, SITAGLIPTIN
2025-06-04
Apotex
MERILOG
INSULIN ASPART-SZJJ
MERILOG is indicated to improve glycemic control in adults and pediatric patients with diabetes mell...
2025-02-14
SANOFI-AVENTIS U.S. LLC
MERILOG SOLOSTAR
INSULIN ASPART-SZJJ
MERILOG is indicated to improve glycemic control in adults and pediatric patients with diabetes mell...
2025-02-14
SANOFI-AVENTIS U.S. LLC
BRYNOVIN
SITAGLIPTIN HYDROCHLORIDE
1 INDICATIONS & USAGE BRYNOVIN is indicated as an adjunct to diet and exercise to improve glycemic c...
2025-01-16
AZURITY
GLP-1GIPDPP-4
LIRAGLUTIDE
LIRAGLUTIDE
Liraglutide injection is indicated: as an adjunct to diet and exercise to improve glycemic control i...
2024-12-23
BIOCON PHARMA
GLP-1DPP-4
TRYNGOLZA (AUTOINJECTOR)
OLEZARSEN SODIUM
TRYNGOLZA is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomi...
2024-12-19
IONIS PHARMS INC
EXENATIDE SYNTHETIC
EXENATIDE SYNTHETIC
2024-11-19
AMNEAL
Showing the 20 most recent of 348 metabolic drugs. View all 348 →

Metabolic Drug Classes

Insulin Analog 26
Sodium-Glucose Cotransporter 2 Inhibitor 9
Dipeptidyl Peptidase 4 Inhibitor 9
GLP-1 Receptor Agonist 8
Sulfonylurea 8
Glucose-dependent Insulinotropic Polypeptide Receptor Agonist 6
Alkaloid 5
Bile Acid Sequestrant 5
Vascular Endothelial Growth Factor Inhibitor 4
HMG-CoA Reductase Inhibitor 4

Metabolic at a Glance

Total Drugs
348
Companies
137
Drug Classes
30
Active Trials
1,438
Latest Approval
2026-04-29